Effects of Exogenous Antioxidants on Dietary Iron Overload by Asare, George A. et al.
85
Original Article J. Clin. Biochem. Nutr., 44, 85–94, January 2009
JCBN Journal of Clinical Biochemistry and Nutrition 0912-0009 1880-5086 the Society for Free Radical Research Japan Kyoto, Japan jcbn08-184 10.3164/jcbn.08-184 Original Article Effects of Exogenous Antioxidants on Dietary Iron Overload
George A. Asare1,*, Michael C. Kew1, Kensese S. Mossanda2, Alan C. Paterson3, Kwanele Siziba4, 
and Christiana P. Kahler-Venter5
1MRC/University Molecular Hepatology Research Unit, Department of Medicine, University of the Witwatersrand,
Johannesburg, 2193, South Africa
2Department of Chemical Pathology, Medical University of South Africa, Pretoria 0204, South Africa
3School of Pathology, Department of Anatomical Pathology, University of the Witwatersrand AND National Health
Services Laboratories, Johannesburg 2193, South Africa
4National Centre for Occupational Health, Johannesburg 2000, South Africa
5Department of Pharmacology, Medical University of South Africa, Pretoria 0204, South Africa
1 2009 ?? 12 2008 44 1 85 94 Received 9.6.2008 ; accepted 26.9.2008
*To whom correspondence should be addressed.    
Tel: +233-244-627-456    Fax: +233-21-688292    
E-mail: gasare@chs.edu.gh
Received 9 June, 2008; Accepted 26 September, 2008
Copyright © 2009 JCBN Summary In dietary iron overload, excess hepatic iron promotes liver damage. The aim was
to attenuate free radical-induced liver damage using vitamins. Four groups of 60 Wistar rats
were studied: group 1 (control) was fed normal diet, group 2 (Fe) 2.5% pentacarbonyl iron
(CI) followed by 0.5% Ferrocene, group 3 (Fe + V gp) CI, Ferrocene, plus vitamins A and E
(42× and 10× RDA, respectively), group 4 (Fe – V gp) CI, Ferrocene diet, minus vitamins A
and E. At 20 months, glutathione peroxidase (GPx), superoxide dismutase (SOD), Oxygen
Radical Absorbance Capacity (ORAC), Ames mutagenicity test, AST, ALT and 4-
hydroxynonenal (4-HNE) immunohistochemistry were measured. 8OHdG levels of the Fe + V
and Fe – V groups were 346 ± 117 and 455 ± 151, ng/g w.wt, respectively. Fe + V and Fe – V
differences were significant (p<0.005). A positive correlation between DNA damage and
mutagenesis existed (p<0.005) within the iron-fed gps. AST levels for Fe + V and Fe – V groups
were 134.6 ± 48.6 IU and 202.2 ± 50.5 IU, respectively. Similarly, ALT levels were 234.6 ±
48.3 IU and 329.0 ± 48.6 IU, respectively. However, Fe – V and Fe + V groups transaminases
were statistically insignificant. 4-HNE was detected in Fe + V and Fe – V gp livers. Vitamins
A and E could not prevent hepatic damage.
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Introduction
Hepatocellular carcinoma (HCC) occurs commonly in
sub-Saharan Africa, with age-adjusted incidences as high as
113/100 000 of the population and annum [1]. Chronic
hepatitis B virus (HBV) infection is the major cause of the
tumor in sub-Saharan Africa [2], although a significant
percentage of the patients cannot be accounted for by this
causal association [3, 4]. Dietary exposure to aflatoxin is
another important etiological association of HCC in some
parts of sub-Saharan Africa [5], particularly in tandem with
HBV infection [6]. A more recently identified risk factor to
HCC is dietary iron overload. This condition occurs in some
rural areas of sub-Saharan Africa [7], with prevalence as
high as 10% [8–12].
Iron is a ubiquitous metal in cells, and a component of
many enzymes and proteins. As a transition element, its
ionic form participates in one-electron transfer reactions,
and this is an important attribute in its role as a prosthetic
group in enzymes that catalyze redox reactions. However,
this capacity also enables iron to generate free radicals. ForG.A. Asare et al.
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example, iron participating in the Fenton reaction will react
with less potent reactive oxygen species (ROS) and free
radicals to produce more potent secondary ROS. Under
pathological conditions, when more ROS are generated, iron
catalyzes the reaction of superoxide (O2￿−) and hydrogen
peroxide (H2O2), resulting in hydroxyl radical (￿OH) forma-
tion [13], which is more damaging to biological molecules,
including lipids, proteins, and nucleic acids [14]. The oxida-
tion products arising from these macromolecules can initiate
tissue injury either directly or indirectly.
Free radicals and ROS are normally removed or inactivated
in vivo by an antioxidant defence system. Antioxidant
enzymes such as superoxide dismutase (SOD), catalase
(CAT) and glutathione peroxidase (GPx) protect cells from
the toxic effects of ROS and free radicals [13]. SOD
converts O2￿− into H2O2, while CAT and GPx convert H2O2
to oxygen and water. Other antioxidants of importance are
vitamins C, E and A. Vitamin E acts as a potent scavenger of
signet oxygen and a chain breaker during lipid peroxidation
(LPO). When vitamin E interacts with a lipid peroxyl radical
it becomes a radical itself. Vitamin C reacts with vitamin E
radical to regenerate vitamin E.
Early epidemiological studies indicated that a diet rich in
yellow vegetables is associated with decreased risk of
cancer [15–17]. In 1981, it was hypothesized that the beta-
carotene present in these vegetables might be responsible for
the observed decrease in cancer rates [18]. Since then, more
than 100 case-control and cohort studies have examined the
association between the intake of vitamins and the risk of
developing various forms of cancers [19]. Five large scale
clinical trials of the effects of different vitamins reached
different conclusions on the effects of antioxidants and
cancer. The Cancer Prevention Study showed that a combi-
nation of beta-carotene, vitamin E and selenium significantly
reduced the occurrence of cancers in healthy individuals
[20]. However, in the Alpha-Tocopherol (vitamin E) and
Beta-Carotene Cancer Prevention Study (ATBC) the inci-
dence of the cancers studied was not affected by vitamin E
[21]. On the contrary, beta-carotene increased lung cancer
risk by 18% [21]. Similarly, the Physician’’ Health Study 1
(PHS) found no change in cancer rates associated with beta-
carotene [22] and neither did the Women’s Health Study
(WHS) find any benefit or harm (with respect to cancers)
from beta-carotene and vitamin E supplementation [23, 24].
On the contrary, beta-carotene and retinol increased the risk
of cancer in the Beta-Carotene and Retinol (vitamin A)
Efficacy Trial (CARET) [25].
These long-term randomised trials raise concerns that
vitamins might actually stimulate the development of cancer
in high-risk individuals [26, 27]. For example, β-carotene
itself may act as an anticarcinogen, but its oxidized products
at high concentrations may facilitate carcinogenesis [28].
Furthermore, vitamins A and E, have been found to be
damaging to mice with brain tumours, probably by pre-
venting cancer cells from self-destruction through apoptosis
[29]. The effectiveness of vitamin antioxidants in carcino-
genesis is therefore still debatable [26, 30].
The aim of this study was to determine whether high
doses of a combination of vitamins A and E could attenuate
the hepatocarcinogenic process initiated by ROS as a result
of dietary iron overload in our animal model [31] of hepatic
iron overload complicated by HCC.
Materials and Methods
Experimental animals
Eighty pregnant Wistar albino (rattus Norvegicus) rats
(of initial weight 200 g ± 5 g before pregnancy) were fed
(ad libitum) a standard chow diet (AIN-93G Formulation).
Four groups made up of 20 pregnant rats each were set up
prior to littering. Immediately after littering, rats were fed
the following dietary regimen: The first group, the control
group, was designated C gp. Groups 2 to 4 were fed a high
iron diet. Group 2 was designated the iron group (Fe gp).
Group 3 (Fe + V gp) received iron plus vitamins A and E
supplementation; 50mg vitamin A per kg diet ≡ 166 500 IU
all trans-retinol (42× RDA) [32–35] and 500 mg vitamin E
per kg diet ≡ 750 IU  α-tocopherol (10× RDA) [36–38].
(Vitamins were purchased from Sigma, Munich, Germany).
Group 4 (Fe – V gp) received a diet enriched with iron but
totally devoid of vitamins A and E. Sixty weaned male rats
(weighing 80 ± 5 g) were selected from each group for the
study and continued on the same diet regimen assigned to
the group. The control group (C) received the standard diet.
In the groups receiving a high iron diet, the diet was supple-
mented with 2.5% pentacarbonyl iron (CI—98.0% purity)
(Sigma, Munich, Germany) according to the protocol of
Plummer et al. [39]. At 12mo, the 2.5% CI was replaced by
0.5% dicyclopentadienyl iron [Fe(C5H5)2] (CAS-102-54-5)
(because of poor iron loading). The rats received humane
care in accordance with the guidelines of the Animal Ethics
Committee of the University. The rats were studied for 32
months. Five (5) rats from each group were sacrificed at 2
months, 4 months and then, every 4 months up until 24
months for blood and liver. One portion of the liver was
snap-frozen in liquid nitrogen (and later stored at −70°C)
and the other kept in 10% buffered formalin. After 24
months, rats were kept solely for histological purposes. All
other experiments were attenuated at 24 months.
Determination of serum iron, blood GPx and SOD
Iron kit (Sigma) was used to determine serum iron con-
centrations. Randox commercial kits (Randox, Laboratories,
Crumlin, UK) were used for blood GPx and SOD. Proce-
dures were followed according to the manufacturer’s
instructions.Exogenous Antioxidants and Dietary Iron Overload
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Determination of liver total antioxidants
Oxygen Radical Absorbance Capacity (ORAC) was
performed on fresh serum to discriminate between water-
soluble and lipid-soluble total antioxidants. ORAC was
measured by a system made up of β-phycoerythrin as a
fluorescent indicator protein, 2-2'-azo-bis (2-amidinpropane)
dihydrochloride as a peroxyl radical generator, and the
water-soluble vitamin E analogue Trolox (Aldrich-Sigma,
Munich, Germany) as a reference standard. The total anti-
oxidant capacity was expressed as ORAC units, where one
unit equals the net protection by 1 μmol Trolox/l [40].
Determination of 8-hydroxy-2'-deoxy-guanosine (8OHdG)
concentration
Hepatic levels of 8OHdG were determined using a
commercial kit from the Japan Institute for the Control of
Aging (Fukuroi, Japan). The 8OHdG test is a competitive in
vitro enzyme-linked immunosorbent assay for the quantita-
tive measurement of 8OHdG in tissue, serum and plasma.
The test was performed according to the manufacturer’s
instructions for liver tissue and the absorbance read at
450 nm on a microplate reader.
Determination of Aspartate Transaminase (AST) and
Alanine Transaminase (ALT)
Serum AST and ALT were measured using an auto-
analyser (Cobas Integra 400, Holliston, MA) and kits from
Roche Diagnostics (Indianapolis, IN).
Ames mutagenicity test
Ames test was performed according to the method of
Maron and Ames [41]. The Salmonella typhimurium TA 102
tester strain was used for the tests. Assays were carried out
on samples of fractionated liver homogenate, namely, whole
homogenate, S9 fraction, nucleosomes, microsomes and the
cytosolic fraction. Samples were assayed according to the
standard plate incorporation test without S9 mix. Dimethyl
sulfoxide (5%) and daunorubicin hydrochloride (5 μg/plate)
were used as negative and positive controls respectively.
Immunohistochemistry
The protocol of Ma et al. [42] was used for 4-hydroxy-2'-
nonenol (4-HNE) detection from paraffin embedded sections
(3 μm-thick). Briefly, slides were incubated at 56–60°C for
15 min, for antigen retrieval. Sections were deparaffinized
in two changes of xylene (5 min each) followed by two
changes of absolute ethanol (5 min each), and briefly in
water. Sections were incubated with 0.3% H2O2 in methanol
for 30 min to block endogenous peroxidases. This was
followed by a similar wash in phosphate buffered saline
(PBS). After incubation in PBS for 15 min, sections were
blocked, for monospecific binding of the antibody, by
incubation in 5% bovine serum albumin (BSA) for 15 min
at room temperature. Sections were then covered in a
humidified chamber with 300–500 μl of 2 μg/ml anti-4HNE
rabbit primary antibody in PBS, overnight at room tempera-
ture. PBS without primary antibody was used as a negative
control. Slides were rinsed with PBS and left in the
buffer for 5 min. 300 μl of biotinylated secondary antibody
[biotinylated rabbit IgG (Sigma) diluted in PBS (1/300)]
was applied onto the sections for at least 30 min at room
temperature. Slides were washed with PBS and covered with
300 μl of ExtrAvidin peroxidase diluted in PBS (1:100) for
at least 30 min of incubation time at room temperature. After
rinsing briefly with PBS, freshly prepared diaminobenzidine
(DAB) substrate mixture was ‘pipetted’ unto the slides to
cover the sections, and incubated for 5–10 min. Slides were
gently rinsed and counter-stained with Meyer’s Haematoxylin
solution for 10 min, followed by brief washing under
running water. [Primary antibodies were obtained from the
Japan Institute for the Control of Aging].
Histology
Formalin-fixed liver specimens for histology were
embedded in paraffin wax. 1 μm sections were stained with
haematoxylin-eosin (H & E) and Perls’ Prussian blue stain.
The degree of iron loading was assessed histologically in
coded sections and graded on a scale of 0–4. Iron-free
foci (IFF) were confirmed by placental-glutathione-sulfhydryl-
transferase (GST-P) immunohistochemical staining.
Statistical analyses
The SAS statistical package was used. All data was
expressed as the mean ± SEM. Statistical analysis was
performed by independent Student’s t test at the level of 0.05
for paired and unpaired data. A probability value of p<0.05
was considered statistically significant. For multiple groups,
analysis of variance (ANOVA) was performed by Bonferroni
(Dunn) Multiple comparison t test. Pearson’s correlation
coefficient was determined within groups. Multiple regres-
sion analysis was performed to determine predictive indica-
tors of oxidative stress.
Results
It should be noted that time/course analysis was done for
antioxidants as seen in the graphs because of its importance
with regards to the study. However, 20 months’ statistical
analysis was chosen in order to compare results of oxidative
damage to the immunohistochemical changes and com-
mencement of neoplasm observed at 20 months.
Serum and liver iron
Serum iron levels at 20 months were as follows: Control
group (C) = 62.5 ± 6.2 μmol/l; Fe ± V group = 119.1 ± 9.2
μmol/l; Fe – V group = 117.4 ± 8.5 μmol/l and Fe group =G.A. Asare et al.
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122.0 ± 10.5 μmol/l. Differences between the iron-loaded
groups compared to the control were significant (p<0.05,
respectively). These results are consistent with similar pub-
lished results [31]. Examination of the livers demonstrated
slow progressive iron loading with a gradient commencing
from zone 1. By 20 months all livers showed grade 4 iron
overload, with hepatocytes in all zones showing uniform
positivity. Furthermore, iron-free foci (IFF) were observed
and detailed histology has been published elsewhere [43].
GPx
GPx levels of iron-overloaded and control rats are shown
in Fig. 1. The curves of all the groups except the Fe – V
group had a similar undulating nature. The control group’s
curve remained the highest up to 4 months. Later the Fe + V
group continued to be the highest from 16 months to the
end. Peak values occurred at 4 and 16 months and declined
between 8 and 12 months. GPx level of the Fe – V group
declined from 2 months, reaching its lowest at 12 months
and increased gradually to a maximum. Furthermore, it was
the lowest at several time-points. Group differences between
4–8 and 12–16 months were statistically significant (p<0.05
each), but not at 20 months. Peak GPx values in the various
groups were as follows: C group = 214 ± 11.9 U/g Hb (4
months), Fe group = 179.1 ± 16.1 U/g Hb (20 mo), Fe + V
gp = 228.8 ± 17.6 U/g Hb (16 mo). Maximum GPx value for
Fe – V group was 176.9 ± 24.9 U/g Hb (24 mo).
SOD
Fig. 2 shows SOD levels of iron-overloaded and control
rats. Curves for all the groups including the control group
showed an undulating pattern. SOD for the C group
remained the highest throughout and the Fe – V group, the
lowest. SOD levels for the Fe + V group were directly below
the C group (4–16 mo) but later declined and was below the
Fe group. Peak values observed between 12 and 16 months
were as follows: C gp = 2165 ± 444 U/g Hb (12 mo), Fe
gp = 1584 ± 360 U/g Hb (16 mo), Fe + V = 1626 ± 199 U/g
Hb (12 mo), Fe – V = 1242 ± 201 U/g Hb (16 mo). At 20
months, group differences were statistically insignificant
(p>0.05) comparing Fe + V and Fe – V groups.
ORAC
Fig. 3 shows ORAC of water- and lipid-soluble fractions.
ORAC-Aqueous phase (ORAC-A) and ORAC-Lipid phase
(ORAC-L) was in the ratio of about 4–5:1. Curves for
ORAC-A showed peaks at 12 months, whilst, ORAC-L
showed peaks at 20 months. In both ORAC-A and ORAC-L,
the curve for the Fe + V group was the lowest up until 12
months. The curve for the Fe group of the ORAC-A fraction
was the highest between 8 and 12 months. In addition, both
curves (ORAC-A and ORAC-L) appeared to operate in an
inverse relationship. When ORAC-A curves were at peak
values, ORAC-L curves were low. Conversely, when
ORAC-L curves were at peak values, ORAC-A curves were
low. The correlation analysis showed a negative correlation
Fig. 1. Interaction Plot of time and group: Blood GPx levels of
the Fe group; Fe + V group; Fe – V group; and the
control group (C). Peak values for Fe + V group; C
group; and Fe group occurred at 16 mo, 4 mo, ≈18 mo,
respectively. *indicates that values are different (p<0.05)
for Fe, Fe + V, Fe – V, groups at 8 and 16 mo compared
to the control group. Furthermore, p<0.05 between the
Fe + V and Fe – V groups at 16 mo. ‡indicates p>0.05;
there were no statistical differences between the various
groups at 20 mo.
Fig. 2. Interaction Plot of time and group: Blood SOD levels of
the Fe group; Fe + V group; Fe – V group; and the
control group (C). Peak values for C group, Fe + V
group, Fe – V group occurred around 12 mo. However,
peak value for Fe group occurred at 16 mo. * indicates
that values of groups are different (p<0.05) for Fe group,
Fe + V group, Fe – V group at 12 mo compared to the
control group; ‡ indicates p>0.05 when Fe + V and
Fe – V groups were compared at 20 mo.Exogenous Antioxidants and Dietary Iron Overload
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between ORAC-L and ORAC-A in the C group (r = −0.390,
p = 0.0412).
8OHdG
In Fig. 4, 8OHdG levels of the Fe + V and Fe – V groups
were 346 ± 117 ng/g & 455 ± 151 ng/g at 20 months.
8OHdG level in the non-vitamin group was 1.3 times higher
compared to the vitamin-supplemented group. Control
values were (123 ± 21 ng/g w.wt). Differences between the
Fe – V and Fe + V groups were also statistically significant
(p<0.005). Furthermore, 8OHdG levels of the iron-loaded
groups were 2–3 times higher compared to the control
group.
Ames mutagenicity test
In Fig. 5, differences between fractionated liver samples
of the Fe – V and Fe + V groups were not statistically
significant. However, all other groups apart from the control
group had mutagenicity levels over 600 revertant colonies
at 20 months compared to 360 in the control group. The
positive control was 570 colonies. Colony differences of
any liver fraction (§, *, ϕ, β, λ) were statistically significant
for all the iron-loaded groups compared to the same fraction
(§, *, ϕ, β, λ) in the control group (p<0.05).
AST/ALT
In Fig. 6, ALT levels of the Fe + V and Fe – V groups at
20 months were 234.6 ± 48.3 IU & 329.0 ± 48.6 IU, respec-
tively. AST levels for the Fe + V and Fe – V groups at 20
Fig. 3. Interaction Plot of time and group: Serum ORAC-
Aqueous phase (ORAC-A) and ORAC-Lipid phase
(ORAC-L) of the Fe group; Fe + V group; Fe – V group;
and the control group (C). ORAC-A and ORAC-L
curves peaked at 12 and 20 mo, respectively. ORAC-A
and ORAC-L appears to operate inversely with a nega-
tive correlation (r = −0.390, p = 0.0412). * indicates that
values are different (p<0.05) at 12 mo when ORAC-A is
compared to ORAC-L (group by group). ‡indicates
p>0.05 at 20 mo when ORAC-A is compared to ORAC-
L (group by group). Furthermore, differences between
ORAC-A and ORAC-L were 4-5-fold and 2-fold,
respectively, at 12 and 20 mo.
Fig. 4. Bar chart of liver 8OHdG levels of Wistar albino rats fed
different diets. Chart indicates 8OHdG levels of the Fe
group; Fe + V group; Fe – V group; and the control
group (C). * indicates that values are different (p<0.05)
when Fe, Fe + V and Fe – V groups, are compared to the
control group (C). ** indicates that values are different
(p<0.005) when Fe + V group is compared to Fe – V
group.
Fig. 5. Bar chart of the level of mutagens produced using
Salmonella typhimurium TA 102 strain in the Plate
Incorporation method of the Ames Mutagenicity Test on
ultracentrifuged liver fractions of C, Fe + V, Fe – V and
Fe groups, respectively at 20 months. Fractions from the
same group whose values are symbolized by §, *, ϕ, β,
λ, are statistically different (p<0.05) compared to
fraction from the control group. Furthermore, ‡ indicates
that values are not different (p>0.05) for fractions §, *,
ϕ, β, λ, of the Fe + V group compared to the Fe – V
group.G.A. Asare et al.
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months were 134.6 ± 48.6 IU & 202.2 ± 50.5 IU, respec-
tively. AST/ ALT levels were 2.0–2.5× higher than the
control group and statistically significant (p<0.05, p<0.05).
Differences between the Fe – V and Fe + V groups were not
statistically significant.
Histology and immunohistochemistry
Detailed histology is presented elsewhere [43]. In
summary, liver tissues in all the iron-fed groups were
heavily loaded (grade 4). First signs of IFF which are
neoplastic nodules were observed at 20 months. IFF have
significantly less or no iron in the foci compared with the
surrounding parenchyma, and these were seen in this study
at 20 months and beyond. In 28 IFF samples out of the 95
iron-overloaded samples examined between 20 and 32
months, 43% belonged to the Fe + V group and 21%
belonged to the Fe – V group. The rest belonged to the Fe
group. In the control group liver sections’ immunohisto-
chemistry (Fig. 7a), there was hardly any brown labelling
observed after exposure to the anti-HNE antibodies.
However, intense brown cytoplasmic granular immuno-
staining was observed in the hepatocytes of the iron-fed
groups (Fig. 7b–d).
Correlation analysis
From Table 1, a strong negative correlation was observed
between SOD and AMES (p = 0.0070, r = −0.7320) in the
control group. In the Fe – V group, SOD and AMES
(p = 0.0349, r = 0.8240); and ORAC-A and ALT (p = 0.0429,
r = 0.5390) correlated positively. In the Fe + V group,
ORAC-A correlated negatively with AST (p = 0.0400, r =
−0.6350). There was a strong positive correlation between
oxidative DNA damage and AMES mutagenicity in all iron-
fed groups (p<0.005).
Regression analysis
From the regression analyses results; in the Fe group,
serum iron significantly affected 8OHdG formation (p =
0.0121). Furthermore, 8OHdG formation significantly con-
tributed to liver damage (ALT) (p = 0.0000). In the Fe + V
group, ORAC-L significantly affected 8OHdG formation
(p = 0.0006). Furthermore, ORAC-L significantly affected
ALT levels (p = 0.0000). In the Fe – V group, ORAC-L
significantly influenced 8OHdG production (p = 0.0050).
Discussion
Iron overload disorders are characterized by the accumu-
lation of Fe in mononuclear phagocytes and parenchymal
cells of the liver and other organs. Our biochemistry results
show that the iron, iron/vitamin and iron/non-vitamin groups
had twice the iron levels of the controls and this was
histologically confirmed as iron overload. Fe is a catalyst
in the Habar-Weiss reaction and is involved in the initiation
and propagation of LPO. Considering the role of iron in
iron-reactions, the question is whether antioxidant vitamins
all trans-retinol (vitamin A) and α-tocopherol (vitamin E)
supplementation, have therapeutic effects in supporting the
antioxidant defence system in dietary iron overload against
liver damage.
The activity of the antioxidant enzyme, GPx, in the livers
of iron-loaded rats fed 1.0%–2.5% carbonyl iron has
previously been measured by Fletcher et al. [44]. No signifi-
cant differences were reported in that study, although there
was a trend of increasing GPx activity in the rats receiving
2.5% carbonyl iron. Similarly, no statistically significant
differences in hepatic GPx concentration in hereditary
hemochromatotosis (HH) patients and controls have been
found [45]. In the present study, vitamins A and E increased
GPx levels, especially in the second half of the rats’ life.
Hamilton  et al. [ 46] also showed that vitamin E supple-
mentation increased GPx activity. However, a homeostatic
control of antioxidants has been suggested [47, 48] and this
was also observed in the present study by the negative
correlation between GPx and ORAC-A. Furthermore, this
study group speculates that the higher ORAC-A levels in the
iron-overloaded groups suggests that oxidative stress in
various tissues lead to an enhanced expression or up-
regulation of antioxidant enzymes, as evidenced by others
[47, 48].
In this study, the control group obtained the highest SOD
levels and the iron/non-vitamin group the lowest, suggesting
that oxidative stress may be influenced by vitamin anti-
oxidants in iron loading conditions, and perhaps the impor-
Fig. 6. Bar chart of serum AST/ALT levels of the control (C)
group, Fe + V group, Fe – V group and Fe group at 20 mo
using the Cobas Integra 400 auto analyzer. */** indicate
that AST/ALT values are different (p<0.05) when
compared to the control group. ‡/‡‡indicate that AST/ALT
values are not statistically different (p>0.05) when
Fe + V group is compared to Fe – V group.Exogenous Antioxidants and Dietary Iron Overload
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tance of SOD in iron-related liver diseases [49]. However,
the low antioxidant protection provided by lipid-soluble
antioxidants (Fig. 3) and its inability to attenuate LPO is
evidenced by the heavy deposition of 4-HNE (Fig. 7b–d), as
similarly observed by others [50,  51]. Furthermore, the
immunohistochemical findings suggest that 4-HNE forma-
tion in the liver could not be attenuated by the combination
of vitamins A and E. Of greater consequence is the fact that
4-HNE, which is a by-product of LPO, is able to interact
with DNA to form exocyclic guanine adducts [52]. Although
the vitamin-supplemented group in this study had signifi-
cantly reduced levels of the guanidine adduct 8OHdG,
compared to the non-vitamin group (Fig. 4), this could not
be translated into anti-mutagenic protection as seen in the
mutagenesis assay (Fig. 5). Contrary to our studies, a few
others have findings to support the role of vitamin E in
reducing products of hepatic peroxidation by the subsequent
normalization of hepatic LPO products such as malondial-
dehyde (MDA) in iron-loaded livers [53, 54]. However, it
must be pointed out that the reduction in hepatic LPO
produced from an initial high level has also been proposed
to be a neoplastic marker [55]. The interpretation of bio-
markers of oxidative damage must therefore be approached
cautiously [56].
Another hepatic preneoplastic marker of greater impor-
tance is the development of IFF, which are nodules of
hepatocytes found in HH [57]. It has been shown that in
iron-overloaded rats with chemically induced liver cancer,
early iron-free preneoplastic nodules are thought to be
involved in hepatocarcingenesis [58], possibly as a result of
mechanisms involving the generation of ROS, LPO and
mutagenesis [31]. In this study, 43% IFF livers belonged to
Fig. 7. Immunohistochemical detection of 4-HNE adducts (arrowed) in iron-overloaded liver sections using 2 μg/ml 4-HNE rabbit
primary antibodies in PBS and biotinylated rabbit IgG secondary antibodies. Freshly prepared DAB stain and Mayer’s
Haematoxylin counter-stain were used. Photomicrograph (a) is negative for 4-HNE (control group). (b) (Fe group); (c) (Fe + V
group), (d) (Fe – V group) are all positive for 4-HNE adducts (arrowed) deposited in the cytoplasmic area.G.A. Asare et al.
J. Clin. Biochem. Nutr.
92
the iron/vitamin-supplemented group and 21% belonged to
the iron/non-vitamin group. This detrimental effect of high
doses of all trans-retinol (vitamin A) and α-tocopherol
(vitamin E) on dietary iron overload is our hypothesis, as
similarly suggested in other disease conditions by Miller
et al. [19] and recently, Bjelakovic [59].
Conclusion
In conclusion, the data presented shows that vitamins A
and E reduced the effects of oxidative stress for a limited
period of time. However, over a prolonged period, high
doses of vitamins A and E could not attenuate the genotoxic
effects of the by-products of ROS and its subsequent oxida-
tive damage on the liver. Furthermore, preneoplastic
markers of HCC appeared to be more common in the iron/
vitamin-supplemented group, than the iron/non-vitamin
group, thereby confirming other epidemiological studies
(ABTS and CARET) and the recent meta-analysis where
high doses of vitamins increased mortality [59].
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transferase; HBV, Hepatitis B Virus; HCC, Hepatocellular
carcinoma; HH, hereditary hemochromatotosis; IFF, Iron
free foci; LPO, Lipid peroxidation; ORAC, Oxygen radical
absorbance capacity; PBS, Buffered phosphate saline; ROS,
Reactive Oxygen Species; SAS, Statistical Analysis Soft-
ware; SEM, Standard Error of the Mean; SOD, Superoxide
dismutase.
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